




版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
Primarybloodstreaminfectionasanindication:RegulatoryperspectiveFDA/IDSA/ISAPWorkshopApril15,2004DavidRoss,M.D.,Ph.D.1OutlineRegulatoryhistoryDefininganti-infective(AI)indicationsPrimarybloodstreaminfectionasanAIindication2Bloodstreaminfection(BSI):history10drugsindicatedforbacteremiaorsepticemiaAlllabeledpriorto1992LabelingbasedonvariableorunspecifiedclinicalmanifestationsindifferentstudiesIncludesbacteremiaassociatedwithfocalinfectionandbacteremiaofunknownoriginPatientspooledfromtrialsofotherindications39/93Anti-InfectiveDrugsACmeetingBacteremiadidnotaffectoutcomeinalargeNDAdatasetBacteremiaisduetoinfectionataprimarysiteBacteremicSIRSpatientsformaheterogeneouspopulationUnclearifbacteremicSIRSpatientsweresickerthannonbacteremicpatients49/93ACconclusionsBacteremialessimportantthansiteofinfectionforclassifyinginfectionsStudyof‘bacteremicsepsis’asaseparateindicationnotfeasiblegivenheterogeneityofpatientpopulationLabelingshouldincludebacteremiainthecontextofsite-specificinfections,e.g.,“pneumoniawithassociatedbacteremia”5ReconsideringBSIasanindicationIncreasedincidenceofBSI:withresistantpathogens(e.g.,VRE,MRSA)withoutidentifiableprimarysourceIssuesinmeasuringdrugeffectinBSI...PatientheterogeneityDifferencesinnaturalhistoryfordifferentpathogensDifferencesinpathogenepidemiology/virulenceNeedtodefineanidentifiableclinicalsyndrome ...beforeconsideringasanindication6Doesbacteremiaequaldestiny?28yofemalewithpatchyinfiltrateinonelobe.Nocomorbidities.HR80,RR16.SCx
→
S.pneumoniaeBCx→
S.pneumoniae.Mortalityrisk<0.1%52yomalewithmultilobarpneumonia.Chronicrenalfailure,uncontrolledDMHR130,RR35.Intubated.SCx
→
S.pneumoniaeBCx→negativeMortalityrisk27%
7NotallbacteremiasarethesameA76yonursinghomeresidentwasadmittedforalteredmentalstatus,hypotension,hypo-thermia,obtundation,andneckstiffness.ACXRshowedbi-lateralinfiltrates.AnLPshowed4,218WBC/μL(89%segs)andglucoseoflessthan20mg/dL.BloodandCSFCxgrewMRSA. DespiteMICUtransfer,therapywithvancomycinandrifampin,andaggressivesupportivecare,thepatientdeterioratedanddied11daysafteradmission.A67yoMwithchronicrenalfailurereceivinghemodialysisviaanarteriovenousgraftwasadmit-tedforfeverto38.0°C;thepatientwasotherwisewell.Nomurmurwasfoundandthegraftwasnon-tender.Thefeverresolvedandvancomycinwasstarted.BCxgrewMRSA.Therewasnofurtherfeverorothersx.ArepeatBCxwaspositive.Atransesophageal
echocardio-gramwasnegative,aswasaDopplerultrasoundofthegraft.Thepatientreceived4weeksofIVvancomycinanddidwell.RepeatBCxwerenegative.8Site-basedanti-infective(AI)indication“Infectionataspecifiedbodysiteduetoaspecified,susceptiblemicroorganism”.(PointstoConsider,1992)AccountsfordifferencesindrugefficacyforinfectionsatdifferentsitesAllowsdemonstrationofefficacyfromadequateandwell-controlledstudiesAllowsdescriptionofdrugeffectinlabeling9EssentialsofanAIindicationMustbearecognizeddiseaseorcondition,oranimportantmanifestationofadiseaseDefinablesyndromewithspecificclinicalmanifestations,diagnosticcriteria,andtherapeuticrequirementsDrugtreatmenteffectdemonstrableviaadequateandwell-controlledtrialsusingclinicallyrelevantendpointsDescribableinlabeling10AIindicationsvs.non-indicationsAIindicationsUrinarytractinfectionOsteomyelitisBacterialmeningitisStreptococcalpharyngitisCommunity-acquiredpneumoniaProphylaxisagainstpost-operativeinfectionNon-indicationsDysuriaElevatedESRComathroatcultureforGASPleuriticchestpainDecreaseinskincolonization11CAPUTIBacteremiaMeningitisEndocarditisComplicatedIABDOsteomyelitisSSTI12BSIvs.bacteremiaCandidalBSI(candidemia)AcceptedAIindicationFrequentlyprimaryBSI(noidentifedunderlyinginfection)DefinableclinicalsyndromeEscherichiacolibacteremiaNotacceptedAIindicationVirtuallyneverprimaryBSIVarietyofpotentialunderlyinginfections(e.g.,GI,GU)Varietyofclinicalmanifestations13BSIvs.(pseudo)bacteremiaPeripheralBCx(n=1408)CatheterBCx(n=1408)pvalueTrueBSI13.7%14.4%0.59Contamination1.8%3.8%0.001Indeterminate0.9%1.6%0.09Negative83.6%80.1%0.02EvertsRJetal.JClinMicrobiol.2001;39:3393-339414BacteremiaasasurrogateendpointChaissonRetal.Ann.Intern.Med.1994;121:905-11Clarithromycindose500mgbid1000mgbid2000mgbidBacterialloadat2weeks(cfu/mL)1453425Mortalityat12weeks5.7%25.5%28.0%15QuestionsIsthereadistinctpatientpopulationwithprimarybacterialBSIthatcanbeidentifiedatthetimeofrandomizationintoaclinicaltrial?Ifyes,howshouldpatientswithbacterialBSIwhodemonstrateevidenceofmetastaticinfectionpost-randomizationbeclassifiedwithregardtoa)whethertheBSIwasprimaryorsecondaryatthetimeofrandomization;b)outcome?W
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 精准医学精准治疗-洞察及研究
- 智能家电与零售科技融合的未来趋势-洞察阐释
- 属性加密技术在电子政务中的应用与安全性分析-洞察阐释
- 基于大数据的干部休养所员工满意度提升策略-洞察阐释
- 肉桂叶精油抗菌纳米纳米材料研究-洞察阐释
- 【中小学科学教育中调查类实践活动的案例设计9100字】
- 【课程标准对语文阅读的要求及建议分析3700字】
- 2025至2030中国男士衬衣行业发展分析及竞争格局与发展趋势预测报告
- 2025至2030中国生姜产品行业市场占有率及投资前景评估规划报告
- 2025至2030中国甑炭行业需求动态及发展前景研究报告
- 智慧农业项目建设方案
- 人工智能模拟题
- 2024年下半年江苏南通启东市部分事业单位选调工作人员14人易考易错模拟试题(共500题)试卷后附参考答案
- 教师资格考试小学美术面试试题及答案指导(2025年)
- 住家保姆合同协议书模板
- AI如何赋能艺术教育-笔记
- DB11T 485-2020 集中空调通风系统卫生管理规范
- 《人力资源管理》全套教学课件
- Unit 6 Craftsmanship Reading 教案-2023-2024学年中职英语高教版(2023修订版)基础模块2
- 2023-2024学年山东省菏泽市东明县八年级(下)期末数学试卷(含答案)
- 初高中物理衔接讲座(初高中物理对比)
评论
0/150
提交评论